Purpose.Escherichia coli is a leading cause of bloodstream infection (BSI) in hospitals and communities.
Methodology. We conducted a retrospective study in 2015 to evaluate the clinical features and microbiological characteristics of E. coli BSI acquired in the hospital and community.
Results. A total of 100 patients with E. coli BSI were enrolled, among whom 60 % had hospital-onset (HO) BSI while 40 % had community-onset (CO) BSI. Patients with HO BSI had higher percentages of haematological disorders, immunosuppression conditions, underwent surgery within 2 weeks and had a higher 30-day mortality. The prevalences of multidrug-resistant and extended-spectrum β-lactamase-producing strains were 81 and 60 %, respectively. Resistance percentages to ampicillin, ampicillin-sulbactam, cefazolin, ceftriaxone, ciprofloxacin and levofloxacin were greater than 50 %. Of the 43 different sequence types (STs) identified, ST131 (15.3 %) was the most common. The serum agglutination rate was 52 % in which 13 O and 11 H serogroups were observed. Among the 36 detected virulence factor (VF) genes, IutA (66 %) and traT (61 %) were the most predominant. papA, papC and papEF were different between the CO and HO BSI groups. VF scores were high (mean >7) in the frequently detected ST95, ST1193 and ST131.
Conclusion. This study revealed that the clinical features of HO and CO E. coli BSI were different. STs and serotypes showed a great diversity in this region while VF genes of the isolates varied between clones.
BhattacharyaA,
NsonwuO,
JohnsonAP,
HopeR.
Estimating the incidence and 30-day all-cause mortality rate of Escherichia coli bacteraemia in England by 2020/21. J Hosp Infect2018; 98:228–231 [View Article][PubMed]
MusichaP,
CornickJE,
Bar-ZeevN,
FrenchN,
MasesaC et al. Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998-2016): a surveillance study. Lancet Infect Dis2017; 17:1042–1052 [View Article][PubMed]
PoolmanJT,
WackerM.
Extraintestinal pathogenic Escherichia coli, a common human pathogen: challenges for vaccine development and progress in the field. J Infect Dis2016; 213:6–13 [View Article][PubMed]
MaidenMC,
BygravesJA,
FeilE,
MorelliG,
RussellJE et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA1998; 95:3140–3145 [View Article][PubMed]
MathersAJ,
PeiranoG,
PitoutJD.
Escherichia coli ST131: The quintessential example of an international multiresistant high-risk clone. Adv Appl Microbiol2015; 90:109–154 [View Article][PubMed]
SantosACM,
ZidkoACM,
PignatariAC,
SilvaRM.
Assessing the diversity of the virulence potential of Escherichia coli isolated from bacteremia in São Paulo, Brazil. Braz J Med Bio Res2013; 46:968–97310 [View Article]
Skjøt-RasmussenL,
EjrnæsK,
LundgrenB,
HammerumAM,
Frimodt-MøllerN.
Virulence factors and phylogenetic grouping of Escherichia coli isolates from patients with bacteraemia of urinary tract origin relate to sex and hospital- vs. community-acquired origin. Int J Med Microbiol2012; 302:129–134 [View Article][PubMed]
Siegman-IgraY,
FourerB,
Orni-WasserlaufR,
GolanY,
NoyA et al. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis2002; 34:1431–1439 [View Article][PubMed]
RheeJY,
KwonKT,
KiHK,
ShinSY,
JungDS et al. Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems. Shock2009; 31:146–150 [View Article][PubMed]
MagiorakosAP,
SrinivasanA,
CareyRB,
CarmeliY,
FalagasME et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect2012; 18:268–281 [View Article][PubMed]
KogaVL,
TomazettoG,
CyoiaPS,
NevesMS,
VidottoMC et al. Molecular screening of virulence genes in extraintestinal pathogenic Escherichia coli isolated from human blood culture in Brazil. Biomed Res Int2014; 2014:1–9 [View Article]
Bou-AntounS,
DaviesJ,
GuyR,
JohnsonAP,
SheridanEA et al. Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014. Euro Surveill2016; 21: [View Article][PubMed]
van der Mee-MarquetNL,
BlancDS,
Gbaguidi-HaoreH,
dos Santos BorgesS,
ViboudQ et al. Marked increase in incidence for bloodstream infections due to Escherichia coli, a side effect of previous antibiotic therapy in the elderly. Front Microbiol2015; 6:646 [View Article][PubMed]
QuanJ,
ZhaoD,
LiuL,
ChenY,
ZhouJ et al. High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China. J Antimicrob Chemother2017; 72:273–280 [View Article][PubMed]
VihtaKD,
StoesserN,
LlewelynMJ,
QuanTP,
DaviesT et al. Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998-2016: a study of electronic health records. Lancet Infect Dis2018; 18:1138–1149 [View Article][PubMed]
ChoSY,
KangCI,
ChaMK,
WiYM,
HaYE et al. Clinical features and treatment outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli sequence type 131. Microb Drug Resist2015; 21:463–469 [View Article][PubMed]
WangS,
ZhaoSY,
XiaoSZ,
GuFF,
LiuQZ et al. Antimicrobial resistance and molecular epidemiology of Escherichia coli causing bloodstream infections in three hospitals in Shanghai, China. PLoS One2016; 11:e0147740 [View Article][PubMed]
XiaS,
FanX,
HuangZ,
XiaL,
XiaoM et al. Dominance of CTX-M-type extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolated from patients with community-onset and hospital-onset infection in China. PLoS One2014; 9:e100707 [View Article][PubMed]
ZhangJ,
ZhengB,
ZhaoL,
WeiZ,
JiJ et al. Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals. BMC Infect Dis2014; 14:659 [View Article][PubMed]
de KrakerME,
JarlierV,
MonenJC,
HeuerOE,
van de SandeN et al. The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. Clin Microbiol Infect2013; 19:860–868 [View Article][PubMed]
AzargunR,
SadeghiMR,
Soroush BarhaghiMH,
Samadi KafilH,
YeganehF et al. The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections. Infect Drug Resist2018; 11:1007–1014 [View Article][PubMed]
ChaMK,
KangCI,
KimSH,
ChoSY,
HaYE et al. Comparison of the microbiological characteristics and virulence factors of ST131 and non-ST131 clones among extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia. Diagn Microbiol Infect Dis2016; 84:102–104 [View Article][PubMed]
SzemiakoK,
KrawczykB,
SametA,
ŚledzińskaA,
NowickiB et al. A subset of two adherence systems, acute pro-inflammatory pap genes and invasion coding dra, fim, or sfa, increases the risk of Escherichia coli translocation to the bloodstream. Eur J Clin Microbiol Infect Dis2013; 32:1579–1582 [View Article][PubMed]
MicenkováL,
BeňováA,
FrankovičováL,
BosákJ,
VrbaM et al. Human Escherichia coli isolates from hemocultures: Septicemia linked to urogenital tract infections is caused by isolates harboring more virulence genes than bacteraemia linked to other conditions. Int J Med Microbiol2017; 307:182–189 [View Article][PubMed]
MendisSM,
VasooS,
JohnstonBD,
PorterSB,
CunninghamSA et al. Clinical and molecular correlates of Escherichia coli bloodstream infection from two geographically diverse centers in Rochester, Minnesota, and Singapore. Antimicrob Agents Chemother2018; 62: [View Article][PubMed]